Home › Cancer (all types) › Texas › League City
Cancer (all types) clinical trials in League City, TX
5 studies for Cancer (all types) are looking for participants at sites in and around League City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- USO - Texas Oncology, Webster · 3 mi away
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecruitingPhase 3
- Tranquil Clinical Research, Webster · 3 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi away
The Gut Microbiome and Immunotherapy Response in Solid Cancers
RecruitingObservational study
- University of Texas Medical Branch, Galveston · 23 mi away
Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study
RecruitingObservational study
- The University of Texas Medical Branch, Galveston · 23 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY109 studies
- Boston, MA85 studies
- Los Angeles, CA74 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Washington, DC58 studies
- Durham, NC58 studies
- Chicago, IL51 studies
- Atlanta, GA49 studies
- Seattle, WA49 studies
- Arlington, VA48 studies
Other studies in League City
- Non-Small Cell Lung Cancer15 studies
- Breast Cancer12 studies
- Metastatic Cancer7 studies
- Ulcerative Colitis6 studies
- Lung Cancer6 studies
- Colorectal Cancer6 studies
- Ovarian Cancer5 studies
- Stroke5 studies
- Bladder Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Prostate Cancer4 studies
- Post-COVID Conditions (Long COVID)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.